Literature DB >> 18063695

The inhibitory collagen receptor LAIR-1 (CD305).

Linde Meyaard1.   

Abstract

The immune system protects the body from invaders such as viruses and bacteria. Immune cells must be activated in the correct context to function properly. It is critical that the receptors, costimulatory molecules, and cytokines that orchestrate this activation are carefully regulated to prevent uncontrolled inflammation and autoimmunity. Inhibitory receptors play an important role in regulation of immune cell function, usually upon interaction with ligands present on other cells. In contrast, the function of the inhibitory leukocyte-associated Ig-like receptor (LAIR)-1 can be regulated by extracellular matrix collagens. LAIR-1 is expressed on most cells of the immune system, and its function has been studied on multiple cell types. This review summarizes current literature about LAIR-1, a receptor that potentially is able to regulate multiple steps of an immune response.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18063695     DOI: 10.1189/jlb.0907609

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  105 in total

1.  Inhibitory receptor expression on neonatal immune cells.

Authors:  J Walk; G H A Westerlaken; N O van Uden; M E Belderbos; L Meyaard; L J Bont
Journal:  Clin Exp Immunol       Date:  2012-08       Impact factor: 4.330

Review 2.  Sequence, structure, function, immunity: structural genomics of costimulation.

Authors:  Kausik Chattopadhyay; Eszter Lazar-Molnar; Qingrong Yan; Rotem Rubinstein; Chenyang Zhan; Vladimir Vigdorovich; Udupi A Ramagopal; Jeffrey Bonanno; Stanley G Nathenson; Steven C Almo
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

3.  Leukocyte-Associated Ig-like Receptor 1 Inhibits Th1 Responses but Is Required for Natural and Induced Monocyte-Dependent Th17 Responses.

Authors:  Vrushali V Agashe; Ewa Jankowska-Gan; Melissa Keller; Jeremy A Sullivan; Lynn D Haynes; John F Kernien; Jose R Torrealba; Drew Roenneburg; Melanie Dart; Marco Colonna; David S Wilkes; William J Burlingham
Journal:  J Immunol       Date:  2018-06-08       Impact factor: 5.422

4.  C1q limits dendritic cell differentiation and activation by engaging LAIR-1.

Authors:  Myoungsun Son; Frances Santiago-Schwarz; Yousef Al-Abed; Betty Diamond
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-23       Impact factor: 11.205

5.  Peripheral CD27-CD21- B-cells represent an exhausted lymphocyte population in hepatitis C cirrhosis.

Authors:  Hiroyoshi Doi; Shiroh Tanoue; David E Kaplan
Journal:  Clin Immunol       Date:  2013-12-17       Impact factor: 3.969

6.  Genome-wide gene expression profiling reveals unsuspected molecular alterations in pemphigus foliaceus.

Authors:  Danielle Malheiros; Rodrigo A Panepucci; Ana M Roselino; Amélia G Araújo; Marco A Zago; Maria Luiza Petzl-Erler
Journal:  Immunology       Date:  2014-11       Impact factor: 7.397

Review 7.  Recognition of additional roles for immunoglobulin domains in immune function.

Authors:  John P Cannon; Larry J Dishaw; Robert N Haire; Ronda T Litman; David A Ostrov; Gary W Litman
Journal:  Semin Immunol       Date:  2009-12-08       Impact factor: 11.130

8.  Genome expression profiling and network analysis of nitrite therapy during chronic ischemia: possible mechanisms and interesting molecules.

Authors:  Christopher B Pattillo; Kai Fang; Sibile Pardue; Christopher G Kevil
Journal:  Nitric Oxide       Date:  2009-12-04       Impact factor: 4.427

9.  Immune checkpoint blockade reveals the stimulatory capacity of tumor-associated CD103(+) dendritic cells in late-stage ovarian cancer.

Authors:  Dallas B Flies; Tomoe Higuchi; Jaryse C Harris; Vibha Jha; Phyllis A Gimotty; Sarah F Adams
Journal:  Oncoimmunology       Date:  2016-05-13       Impact factor: 8.110

10.  The immune inhibitory receptor LAIR-1 is highly expressed by plasmacytoid dendritic cells and acts complementary with NKp44 to control IFNα production.

Authors:  Irene Bonaccorsi; Claudia Cantoni; Paolo Carrega; Daniela Oliveri; Gabrielle Lui; Romana Conte; Michele Navarra; Riccardo Cavaliere; Elisabetta Traggiai; Marco Gattorno; Alberto Martini; Maria Cristina Mingari; Alessandro Moretta; Guido Ferlazzo
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.